HEALTHTRUST EUROPE LLP (HTE) ACTING AS AGENT FOR THE UNIVERSITY HOSPITALS OF COVENTRY AND WARWICKSHIRE NHS TRUST (`UHCW`) has floated a tender for Contract notice: Pathology services. The project location is United Kingdom and the tender is closing on 15 Apr 2020. The tender notice number is 154330-2020, while the TOT Ref Number is 41961509. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : United Kingdom

Summary : Contract notice: Pathology services

Deadline : 15 Apr 2020

Other Information

Notice Type : Tender

TOT Ref.No.: 41961509

Document Ref. No. : 154330-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTHTRUST EUROPE LLP (HTE) ACTING AS AGENT FOR THE UNIVERSITY HOSPITALS OF COVENTRY AND WARWICKSHIRE NHS TRUST (`UHCW`)
Office Name: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (`UHCW`)
Address: 19 George Road
Town: Birmingham
Postal Code: B15 1NU


Phone: +44 08458875000
United Kingdom
Email :daniel.chapman@htepg.com
URL :https://healthtrusteurope.bravosolution.co.uk

Tender Details

Object of the contract
Pathology services

Description: Contract notice: Pathology services

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: Not specified
Award criteria: The most economic tender
CPV code: 85111800, 33696200, 38911000, 38912000, 85111800, 85111800, 33696200, 38911000, 38912000
CPV Description: Pathology services.

Blood-testing reagents.

Manual swab test kits.

Automated swab test kits.

Covid-19 Testing

Health Trust Europe is seeking to establish a framework agreement for the supply of Covid-19 Testing equipment, consumables and related services. The framework will be structured into two lots. The first lot will provide a comprehensive range of Covid-19 point of care testing rapid diagnostic testing products to include handheld devices, bench-top devices, connected and non-connected devices, as well as consumables, such as test strips and cassettes, and other products that can be properly described as point of care or near-patient testing for Covid-19. The second lot will provide a comprehensive range of laboratory testing equipment, reagents, associated consumables and services for lab testing of Covid-19.

The first lot will provide a comprehensive range of Covid-19 point of care testing rapid diagnostic testing products to include handheld devices, bench-top devices, connected and non-connected devices, as well as consumables, such as test strips and cassettes, and other products that can be properly described as point of care or near-patient testing for Covid-19.

Lot 1 (Covid-19 Point of Care Testing) will be four product groups:

1) Antibody Testing

2) Antigen Testing

3) IgM Testing

4) IgG Testing.

It is not a requirement for the Successful Tenderer(s) to provide product offerings in all product groups. The Successful Tenderer(s) must provide a product offering which meets the requirement of at least one of the product groups.

HTE is a central purchasing body who is able to carry out this tender exercise by virtue of its appointment as an agent of UHCW. Notwithstanding HTE`s relationship with UHCW, it is HTE conducting this tender exercise and will execute the resultant framework agreement with successful bidders. The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation 2 of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users:

(1)All National Health Service (NHS) bodies in England, including but not limited to (i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx); (ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx); (iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx); (iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx); (v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx); (vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx); (vii) special health authorities (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx); (viii) NHS England; and (ix) clinical senates and strategic clinical networks. (2) All NHS bodies in Wales, including but not limited to all; (i) health boards; (ii) NHS trusts; (iii) the national delivery group; (iv) community health councils; and (v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure. (3) All NHS bodies in Northern Ireland (known as Health & Social Care), including but not limited to: (i) health and social care trusts (as listed at: http://online.hscni.net/?s=Trust); (ii)health agencies (as listed at: http://online.hscni.net/?s=health+agencies); (iii)hospitals (as listed at: http://online.hscni.net/?s=hospitals); (4) Other public bodies, and public corporations (as listed at: https://www.gov.uk/government/organisations). (5) Devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament, and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at: http://www.assembly.wales/en/abthome/role-of-assembly-how-it-works/Pages/governance-of-wales.aspx (6) The Ministry of Defence (as detailed at: https://www.gov.uk/government/organisations/ministryofdefence). Any private sector (i.e. all non-public sector) organisations operating in the United Kingdom and/or any country in the European Union which are of a health and/or social care nature who may also use this framework agreement, including HCA International Limited. This list includes each organisation`s successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes. This framework agreement will be open to any bodies or organisations operating in the UK of a health, and/or social care nature or which have a similar procurement need, and/or any UK based central government authority listed at Annex of Directive 2014/24/EU, in respect of any goods or services to any of the above listed organisation.

Terms and Conditions/Activity Based Income (ABI).

These terms and conditions include provisions requiring the payment by the supplier of an activity based income management charge in consideration of the award of this contract and the management and administration by HTE of the overall contractual structure and associated documentation.


Internet address (URL): https://healthtrusteurope.bravosolution.co.uk

Documents

 Tender Notice